Mayo Clinic's groundbreaking review is revolutionizing how doctors diagnose and treat meningioma, the most common primary brain tumor, by shifting toward precision oncology and patient-centered care. This new approach promises better outcomes and more tailored treatment plans for patients facing this challenging diagnosis.
Targeted cancer therapies are revolutionary—but they fail for up to 60% of patients who should benefit from them. New research from MIT is finally explaining why, and the answer could transform how we treat cancer.
Every week, researchers announce promising new cancer therapies—but most never make it to patients. Discover what separates genuine clinical advances from interesting science, and why the standards for publishing cancer research matter more than ever.
A groundbreaking study reveals that combining genetic risk factors with traditional clinical assessments can dramatically improve how doctors identify people at risk for coronary artery disease. This integrated approach is reshaping what major health organizations recommend for heart disease prevention.
In a major milestone for genomic sequencing technology, Ultima Genomics' UG200 Series has been selected to support Basecamp Research's ambitious Trillion Gene Atlas project. This partnership represents a significant leap forward in combining cutting-edge sequencing with artificial intelligence to accelerate therapeutic discovery.
Why does the same cancer treatment produce dramatically different results in different patients? A groundbreaking study reveals a surprising answer hidden inside our cells' recycling centers—and it could revolutionize how we predict treatment success.